Prospective study of the influence of beams pain descendants inhibitors on the efficacy of milnacipran used for fibromyalgia.

Trial Profile

Prospective study of the influence of beams pain descendants inhibitors on the efficacy of milnacipran used for fibromyalgia.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Milnacipran (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Oct 2016 This trial was completed in France (end date: 2016-06-09), according to European Clinical Trials Database.
    • 09 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top